136 related articles for article (PubMed ID: 21042320)
1. TET2 mutations in childhood leukemia.
Langemeijer SM; Jansen JH; Hooijer J; van Hoogen P; Stevens-Linders E; Massop M; Waanders E; van Reijmersdal SV; Stevens-Kroef MJ; Zwaan CM; van den Heuvel-Eibrink MM; Sonneveld E; Hoogerbrugge PM; van Kessel AG; Kuiper RP
Leukemia; 2011 Jan; 25(1):189-92. PubMed ID: 21042320
[No Abstract] [Full Text] [Related]
2. TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.
Bahari G; Hashemi M; Naderi M; Taheri M
Asian Pac J Cancer Prev; 2016; 17(8):3959-62. PubMed ID: 27644645
[TBL] [Abstract][Full Text] [Related]
3. [Mutations in TET2 in myeloid cancers].
Bernard OA; Delhommeau F; Fontenay M; Vainchenker W
Med Sci (Paris); 2009 Oct; 25(10):785-8. PubMed ID: 19849974
[No Abstract] [Full Text] [Related]
4. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
5. Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.
Li MJ; Yang YL; Lee NC; Jou ST; Lu MY; Chang HH; Lin KH; Peng CT; Lin DT
J Formos Med Assoc; 2016 Sep; 115(9):801-6. PubMed ID: 26414667
[TBL] [Abstract][Full Text] [Related]
6. Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.
Couronné L; Lippert E; Andrieux J; Kosmider O; Radford-Weiss I; Penther D; Dastugue N; Mugneret F; Lafage M; Gachard N; Nadal N; Bernard OA; Nguyen-Khac F
Leukemia; 2010 Jan; 24(1):201-3. PubMed ID: 19710701
[No Abstract] [Full Text] [Related]
7. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
[No Abstract] [Full Text] [Related]
8. Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.
Liu WJ; Tan XH; Luo XP; Guo BP; Wei ZJ; Ke Q; He S; Cen H
Leuk Lymphoma; 2014 Dec; 55(12):2691-8. PubMed ID: 24524305
[TBL] [Abstract][Full Text] [Related]
9. Association of Leukemia Target Genes
Li J; Zhang W; Liu W; Rong J; Chen Y; Gu W; Zhang W
Cancer Genomics Proteomics; 2019; 16(5):333-344. PubMed ID: 31467227
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 21 tandem repetition and AML1 (RUNX1) gene amplification.
Ferro MT; Hernaez R; Sordo MT; Garcia-Sagredo JM; Garcia-Miguel P; Fernández Guijarro M; Lopez J; Villalón C; Vallcorba I; Cabello P; San Roman C
Cancer Genet Cytogenet; 2004 Feb; 149(1):11-6. PubMed ID: 15104277
[TBL] [Abstract][Full Text] [Related]
12. Low expression of TET2 gene in pediatric acute lymphoblastic leukemia is associated with poor clinical outcome.
Zhang P; Weng WW; Chen P; Zhang Y; Ruan JF; Ba DD; Xu WQ; Tang YM
Int J Lab Hematol; 2019 Oct; 41(5):702-709. PubMed ID: 31441600
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group.
Kutny MA; Alonzo TA; Gamazon ER; Gerbing RB; Geraghty D; Lange B; Heerema NA; Sung L; Aplenc R; Franklin J; Raimondi SC; Hirsch BA; Konkashbaev A; Cox NJ; Onel K; Gamis AS; Meshinchi S
Leukemia; 2015 Dec; 29(12):2424-6. PubMed ID: 26126966
[No Abstract] [Full Text] [Related]
14. Familial myeloid malignancies with germline TET2 mutation.
Duployez N; Goursaud L; Fenwarth L; Bories C; Marceau-Renaut A; Boyer T; Fournier E; Nibourel O; Roche-Lestienne C; Huet G; Beauvais D; Berthon C; Cambier N; Quesnel B; Preudhomme C
Leukemia; 2020 May; 34(5):1450-1453. PubMed ID: 31827242
[No Abstract] [Full Text] [Related]
15. Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype.
Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Lee IK; Kim NY; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim N; Yoshida K; Ogawa S; Kim DD
Haematologica; 2015 Sep; 100(9):e351-3. PubMed ID: 26045292
[No Abstract] [Full Text] [Related]
16. Mutations of the E2F4 gene in hematological malignancies having microsatellite instability.
Komatsu N; Takeuchi S; Ikezoe T; Tasaka T; Hatta Y; Machida H; Williamson IK; Bartram CR; Koeffler HP; Taguchi H
Blood; 2000 Feb; 95(4):1509-10. PubMed ID: 10666234
[TBL] [Abstract][Full Text] [Related]
17. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A
Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826
[TBL] [Abstract][Full Text] [Related]
18. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
Das AB; Kakadia PM; Wojcik D; Pemberton L; Browett PJ; Bohlander SK; Vissers MCM
Blood Cancer J; 2019 Oct; 9(10):82. PubMed ID: 31578317
[No Abstract] [Full Text] [Related]
19. Molecular genetics of childhood leukemias.
Rubnitz JE; Look AT
J Pediatr Hematol Oncol; 1998; 20(1):1-11. PubMed ID: 9482406
[TBL] [Abstract][Full Text] [Related]
20. Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias.
Eguchi M; Eguchi-Ishimae M
Med Pediatr Oncol; 2001 Oct; 37(4):417. PubMed ID: 11568912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
